Analyst	Recommendation	Action	Price target	Projected	Date
John Ivankoe J.P. Morgan	Hold	Maintained	$12.00	+66.7%	09/29/2026
Sharon Zackfia William Blair	Buy	Maintained	-	-	09/15/2026
Unknown Analyst Robert W. Baird	Hold	Downgraded	$10.00	+38.9%	08/24/2026
Chris O`Cull Robert W. Baird	Hold	Downgraded	$10.00	+38.9%	08/24/2026
Brian Mullan Piper Sandler	Hold	Maintained	$9.00	+25%	08/17/2026
Brian Harbour Morgan Stanley	Hold	Reiterated	$9.00	+25%	08/12/2026
Matt Curtis D.A. Davidson	Buy	Maintained	$15.00	+108.3%	05/12/2026
Brian Vaccaro Raymond James	Buy	Maintained	$20.00	+177.8%	04/21/2026
Andy Barish Jefferies	Buy	Reiterated	$27.00	+275%	03/06/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	51.47M	53.64M	55.45M	63.00M
Cost of goods sold	29.10M	30.55M	31.21M	35.27M
Cost of revenue	29.10M	30.55M	31.21M	35.27M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	24.24M	16.72M	17.02M	18.44M
Operating expense	28.77M	21.30M	21.56M	23.62M
Total operating expenses	57.88M	51.85M	52.78M	58.90M
Operating income	-6.41M	1.79M	2.68M	4.10M
Other non operating income	-6.87M	335.00K	-352.00K	-258.00K
EBT including unusual items	-16.14M	1.80M	1.90M	3.32M
EBT excluding unusual items	-16.14M	1.80M	1.90M	3.32M
Income tax expense	31.00K	222.00K	103.00K	101.00K
Effective tax rate	-0.19%	12.31%	5.42%	3.04%
Other operating expenses	-	-	-	-
Net income	-712.00K	652.00K	378.00K	1.22M
Net profit margin	-1.38%	1.22%	0.68%	1.93%
Earnings per share	1.05	0.09	0.11	0.13
Interest and investment income	103.00K	94.00K	163.00K	64.00K
Interest expense	-2.97M	-416.00K	-585.00K	-589.00K
Net interest expenses	-2.87M	-322.00K	-422.00K	-525.00K
Depreciation and amortization charges	3.03M	3.34M	3.45M	3.93M
EBITDA	-3.38M	5.13M	6.13M	8.03M
Gain or loss from assets sale	-	-	-	165.00K

Ask anything